NASDAQ:FULC | Profit Breakdown | Fulcrum Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$29.31M-$26.18M
2026-03-31-$22.19M-$18.89M
2025-12-31$0.00-$22.69M-$20.33M
2025-09-30$0.00-$21.86M-$19.6M
2025-06-30$0.00-$19.82M-$17.3M
2025-03-31-$20.4M-$17.66M
2024-12-31$0.00-$19.43M-$16.57M
2024-09-30$0.00-$25.13M-$21.7M
2024-06-30$80M$52.49M$55.41M
2024-03-31$0.00-$29.83M-$26.87M
2023-12-31$871,000.00-$27.99M-$24.76M
2023-09-30$759,000.00-$27.44M-$24.02M
2023-06-30$880,000.00-$27.29M-$23.78M
2023-03-31$295,000.00-$27.94M-$24.78M
2022-12-31$685,000.00-$27.97M-$26.14M
2022-09-30$1.18M-$24.36M-$23.74M
2022-06-30$1.88M-$34.24M-$34.07M
2022-03-31$2.59M-$26M-$25.93M
2021-12-31$11.36M-$23.56M-$23.48M
2021-09-30$4.94M-$20.77M-$20.72M
2021-06-30$4.38M-$19.68M-$19.65M
2021-03-31$4.79M-$17.04M-$17M
2020-12-31$4.23M-$17.79M-$17.72M
2020-09-30$1.85M-$19.1M-$18.96M
2020-06-30$2M-$15.92M-$15.69M
2020-03-31$750,000.00-$18.8M-$18.45M
2019-12-31-$16.49M-$16.12M
2019-09-30-$17.01M-$16.54M
2019-06-30-$13.49M-$13.17M
2019-03-31-$37.23M-$36.84M
2018-12-31-$9.25M-$8.86M
2018-09-30-$9.09M-$8.94M
2018-06-30-$7.85M-$7.85M
2018-03-31-$6.94M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$0.00-$84.77M-$74.88M
2024-12-31$80M-$21.9M-$9.73M
2023-12-31$2.81M-$110.66M-$97.34M
2022-12-31$6.34M-$112.56M-$109.87M
2021-12-31$19.16M-$81.05M-$80.85M
2020-12-31$8.82M-$71.61M-$70.82M
2019-12-31-$84.22M-$82.68M
2018-12-31-$33.5M-$32.59M